Loading...

Intellectia LogoIntellectia
Auto Trade
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BRID
BRID logo

BRID Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bridgford Foods Corp (BRID) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.180
1 Day change
-1.44%
52 Week Range
10.700
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Bridgford Foods Corp (BRID) is not a strong buy at the moment for a beginner, long-term investor. The technical indicators suggest a bearish trend, and there are no significant positive catalysts or proprietary trading signals to support an immediate purchase. While insider buying has increased and revenue has grown, the company's financial performance still shows significant losses, and there is no recent news or valuation data to justify a strong entry point.

Technical Analysis

The technical indicators show a bearish trend. The MACD histogram is negative and contracting, the RSI is neutral at 36.09, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 7.332, with key support at 7.087 and resistance at 7.576.

Positive Catalysts

  • Insiders are buying, with a 336.66% increase in buying activity over the last month. Revenue increased by 5.01% YoY in Q4 2025.

Neutral/Negative Catalysts

  • The company posted a net loss of -6.75M in Q4 2025, despite an improvement YoY. Gross margin dropped significantly by -48.17% YoY. Technical indicators are bearish, and there are no recent news or valuation updates.

Financial Performance

In Q4 2025, revenue increased by 5.01% YoY to $75.85M, net income improved significantly YoY but remains negative at -$6.75M, and EPS increased to -0.74. However, gross margin dropped sharply to 13.16%, down -48.17% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price targets are available for Bridgford Foods Corp (BRID).

Wall Street analysts forecast BRID stock price to rise
Analyst Rating
0
Wall Street analysts forecast BRID stock price to rise
Buy
Hold
Sell
0
Current: 7.285
sliders
Low
0
Averages
0
High
0
0
Current: 7.285
sliders
Low
0
Averages
0
High
0
Wells Fargo
Tiago Fauth
Overweight
maintain
$84 -> $88
AI Analysis
2026-01-20
Reason
Wells Fargo
Tiago Fauth
Price Target
$84 -> $88
AI Analysis
2026-01-20
maintain
Overweight
Reason
Wells Fargo analyst Tiago Fauth raised the firm's price target on BridgeBio to $88 from $84 and keeps an Overweight rating on the shares. The firm notes Attruby revenues posted a solid Q4 beat, and Wells is raising its FY26 estimates by up 10%. The firm conservatively models some seasonality for Q1 but consistent quarter-over-quarter growth Q2-Q4 in 2026.
Truist
Buy
maintain
$80 -> $86
2026-01-08
Reason
Truist
Price Target
$80 -> $86
2026-01-08
maintain
Buy
Reason
Truist raised the firm's price target on BridgeBio to $86 from $80 and keeps a Buy rating on the shares. The firm updated its model, but tells investors in a research note that the fundamental views remain intact from 2025.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BRID
Unlock Now

People Also Watch